CompletedPhase 3NCT05795699
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Studying Corneal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kowa Research Institute, Inc.
- Principal Investigator
- Shona Pendse, MD, MMScKowa Pharma Development Co.
- Intervention
- Ripasudil(drug)
- Enrollment
- 107 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- Keck Hospital of USC, Los Angeles, California, United States
- Macy Eye Center, Los Angeles, California, United States
- Jules Stein Eye Institute, Los Angeles, California, United States
- Byers Eye Institute at Stanford, Palo Alto, California, United States
- Sacramento Eye Consultants, Sacramento, California, United States
- Gorovoy MD Eye Specialists, Fort Myers, Florida, United States
- University of Florida, Gainesville, Florida, United States
- Bascom Palmer Eye Institute, Miami, Florida, United States
- Bascom Palmer Eye Institute - Naples, Naples, Florida, United States
- Eye Consultants of Atlanta, Atlanta, Georgia, United States
- Grene Vision Group, Wichita, Kansas, United States
- University of Kentucky, Lexington, Kentucky, United States
- Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
- W Kellogg Eye Center, Ann Arbor, Michigan, United States
- Verdier Eye Center, Grand Rapids, Michigan, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05795699 on ClinicalTrials.govOther trials for Corneal dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07217249Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsCase Western Reserve University
- RECRUITINGNANCT07373821Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)University Hospital Heidelberg
- RECRUITINGPHASE2NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyDesign Therapeutics, Inc.
- RECRUITINGNANCT06844123Microsurgical Robot-assisted Corneal TransplantCHU de Reims
- RECRUITINGNANCT06425666Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal DystrophyUniversity of Cologne
- RECRUITINGNCT06966167Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With CataractsEye & ENT Hospital of Fudan University
- RECRUITINGNCT06859411Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort StudyCentre Hospitalier Régional Metz-Thionville
- RECRUITINGPHASE3NCT05275972Descemet Endothelial Thickness Comparison Trial IIStanford University